Results 171 to 180 of about 304,634 (351)
Neveen Nawzad Mahmood,1 Ban Mousa Rashid,1 Sakar Karem Abdulla,1 Bushra Hassan Marouf,2 Karmand Salih Hamaamin,2 Hemn Hassan Othman1 1Department of Basic Sciences-College of Pharmacy, University of Sulaimani, Sulaimani-Kurdistan Region, Iraq; 2Department
Mahmood NN +5 more
doaj
Antibody‐Mediated T‐Cell Reduction or Increased Levels of Chimerism Overcome Resistance to Cyclophosphamide‐Induced Tolerance in NKT‐Deficient Mice [PDF]
Tatsushi Onzuka +6 more
openalex +1 more source
Limited evidence exists synthesizing the risk of acute kidney injury (AKI) associated with the concomitant administration of multiple nephrotoxic drugs, and even less examining the concept of nephrotoxic burden. The objective of this scoping review was to (1) identify definitions of nephrotoxic burden; (2) methods used to quantify (use of calculations)
Wafa Alatawi +6 more
wiley +1 more source
Comparing efficacy of neoadjuvant therapy of triple-negative breast cancer: A Bayesian network meta-regression analysis. [PDF]
Jiang Y +8 more
europepmc +1 more source
Notes on some immunosuppressive agents and their use in human liver transplant recipients [PDF]
Groth, CG +6 more
core
FRI0326 Immune cellular profile associated with different treatment outcome in patients with systemic lupus erythematosus on cyclophosphamide [PDF]
Gabriela Gabčová +9 more
openalex +1 more source
Abstract Quantitative risk assessments of chemicals are routinely performed using in vivo data from rodents; however, there is growing recognition that non‐animal approaches can be human‐relevant alternatives. There is an urgent need to build confidence in non‐animal alternatives given the international support to reduce the use of animals in toxicity ...
Marc A. Beal +14 more
wiley +1 more source
Delayed-release budesonide combined with cyclophosphamide in a patient with IgA nephropathy with eGFR < 30 mL/min/1.73 m²: A case report. [PDF]
Yao Z, Wang P, Fu Q, Zhang P.
europepmc +1 more source

